Language Select
Varian Logo

Recent News

February 06, 2019
Varian (NYSE: VAR) today announced its Eclipse™ treatment planning system and TrueBeam® treatment system have been named Category Leaders in the 2019 Best in KLAS: Software and Services Report... Read more
February 05, 2019
Varian (NYSE: VAR) today announced it will be demonstrating a portfolio of smarter cancer care software solutions, February 12-14 in Orlando, FL at HIMSS19, booth 6143. Envisioning a world without... Read more
January 23, 2019
First Quarter 2019 Summary – Oncology gross orders grew 16% in dollars, or 17% in constant currency – Total company revenues grew 9% in dollars, or 10% in constant currency, to $741 million... Read more

Recent Blog Posts

Feb 11, 2019 | Centerline
Multi-Criteria Optimization (MCO) is a clinical decision support tool that was added to Varian’s Eclipse™ treatment planning system in version 15.5. MCO enables clinicians to quickly improve plan... Read more
Jan 31, 2019 | Centerline
The Halcyon™ system is expanding access to high-quality image-guided intensity-modulated radiation therapy (IMRT) and volumetric IMRT (VMAT), enabling clinicians world-wide to provide sophisticated... Read more
Dec 13, 2018 | Centerline
ARIA® for Medical Oncology was recently rolled out across Northern Ireland. As a result, every cancer patient in a province of nearly two million people now has a clinical record within the ARIA... Read more

Get News Releases by Email
Subscribe Now

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com